USA – FDA drafts guidance on classification category for biosimilar supplements
The US Food and Drug Administration (FDA) just published draft guidance to assist sponsors determine the appropriate supplement category for biosimilar applications and its goals for reviewing them. The guidance also describes the process for submitting supplements.
The FDA Draft guidance can be found on its website.
More information on RIS.World.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (12 mars 2024). USA – FDA drafts guidance on classification category for biosimilar supplements. ELSIBI. Consulté le 19 février 2026 à l’adresse https://doi.org/10.58079/w08c





